TLPH
Talphera Inc.
NASDAQ: TLPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.91
+12.40% today
Updated 2026-04-30
Market cap
$38.27M
P/E ratio
—
P/S ratio
1,366.72x
EPS (TTM)
$-0.34
Dividend yield
—
52W range
$0 – $2
Volume
0.2M
Talphera Inc. (TLPH) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $1.07M | $2.39M | $29.50M | $5.22M | $19.26M | $17.36M | $8.00M | $2.15M | $2.29M | $5.42M | $378000.00 | $1.77M | $651000.00 | $0.00 | $28000.00 |
| Revenue growth (YoY) | — | — | — | — | — | +123.3% | +1132.3% | -82.3% | +269.2% | -9.9% | -53.9% | -73.1% | +6.4% | +136.6% | -93.0% | +368.5% | -63.2% | -100.0% | — |
| Cost of revenue | $216000.00 | $383000.00 | $481000.00 | $479000.00 | — | $605000.00 | $26.29M | $24.52M | $24.26M | $12.31M | $10.66M | $3.98M | $6.81M | $6.03M | $3.01M | $1.65M | $5.55M | $6.72M | — |
| Gross profit | $-216000.00 | $-383000.00 | $-481000.00 | $-479000.00 | $1.07M | $1.79M | $3.21M | $-19.30M | $-5.00M | $5.04M | $-2.66M | $-1.82M | $-4.52M | $-616000.00 | $-2.63M | $-1.65M | $-4.89M | $-6.72M | $28000.00 |
| Gross margin | — | — | — | — | 100.0% | 74.7% | 10.9% | -370.0% | -25.9% | 29.0% | -33.3% | -84.8% | -197.3% | -11.4% | -695.2% | -93.0% | -751.9% | — | 100.0% |
| R&D | $8.21M | $18.32M | $15.50M | $8.19M | $13.62M | $24.91M | $26.29M | $24.52M | $22.49M | $21.40M | $19.41M | $13.14M | $4.66M | $4.02M | $2.44M | $1.69M | $5.55M | $6.72M | $6.03M |
| SG&A | — | — | — | — | $6.80M | $7.20M | $9.88M | $18.35M | $14.20M | $15.60M | — | $20.27M | $43.93M | $36.33M | $30.93M | $17.01M | $11.99M | $8.53M | $7.48M |
| Operating income | $-10.29M | $-20.69M | $-19.03M | $-12.19M | $-19.35M | $-29.71M | $-6.67M | $-37.65M | $-19.20M | $-31.96M | $-38.68M | $-35.73M | $-54.20M | $-40.96M | $-18.12M | $-20.35M | $-16.89M | $-15.25M | $-13.48M |
| Operating margin | — | — | — | — | -1805.2% | -1241.1% | -22.6% | -721.7% | -99.7% | -184.1% | -483.8% | -1660.9% | -2368.1% | -756.3% | -4792.6% | -1149.2% | -2594.3% | — | -48157.1% |
| EBITDA | $-9.39M | $-19.88M | $-18.40M | $-12.47M | $-17.28M | $-29.11M | $-6.07M | $-29.85M | $-16.25M | $-28.99M | $-36.43M | $-34.01M | $-49.03M | $-35.22M | $-16.14M | $61.90M | $-16.79M | $-15.16M | $-13.48M |
| EBITDA margin | — | — | — | — | -1611.8% | -1215.9% | -20.6% | -572.1% | -84.4% | -167.0% | -455.6% | -1581.3% | -2142.2% | -650.2% | -4270.6% | 3495.3% | -2579.6% | — | -48157.1% |
| EBIT | $-9.61M | $-20.26M | $-18.88M | $-12.95M | $-17.79M | $-29.71M | $-6.67M | $-30.71M | $-18.23M | $-31.04M | $-38.17M | $-34.59M | $-50.70M | $-37.07M | $-18.12M | $60.25M | $-16.89M | $-15.25M | — |
| Interest expense | $25000.00 | $404000.00 | $1.24M | $1.40M | $2.31M | $3.65M | $16.76M | $2.64M | $5.41M | $12.15M | $14.04M | $12.56M | $2.54M | $3.31M | $2.29M | $1.12M | $134000.00 | $394000.00 | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.63M | $-20.66M | $-20.12M | $-14.34M | $-20.10M | $-33.36M | $-23.43M | $-33.35M | $-24.40M | $-43.16M | $-51.51M | $-47.15M | $-53.24M | $-40.38M | $-35.10M | $42.52M | $-18.40M | $-13.00M | $-14.29M |
| Net income growth (YoY) | — | -114.6% | +2.6% | +28.7% | -40.1% | -66.0% | +29.8% | -42.4% | +26.8% | -76.9% | -19.4% | +8.5% | -12.9% | +24.2% | +13.1% | +221.1% | -143.3% | +29.3% | -9.9% |
| Profit margin | — | — | — | — | -1875.1% | -1393.6% | -79.4% | -639.3% | -126.7% | -248.6% | -644.3% | -2192.0% | -2325.9% | -745.6% | -9285.4% | 2400.6% | -2826.0% | — | -51035.7% |